The Infected Blood Compensation Scheme Regulations 2025
Write the words of this act the way you think they should read. Solon shows your change as a redline against the published text and pins it to that exact text, so it can never be applied to wording you did not see.
Change 1
79 Payment of future financial loss and care awards where an SSP recipient dies
(1) Where the IBCA is notified that an infected SSP recipient or an affected SSP recipient (“E”) has died, the IBCA must determine which is the greater of— (a) E’s future loss (see paragraph (1A)), or (b) E’s post-implementation support scheme amount (see paragraph (1B)). (1A) For the purposes of paragraph (1)(a), E’s future loss is, where E was immediately before they died— (a) an infected SSP recipient, the sum of the future amounts (see regulation 7(1A)(b) and (1B)(b)) of each award mentioned in paragraph (2) determined in relation to E; (b) an affected SSP recipient, the sum of the future amounts determined in accordance with paragraphs (2A) to (2C), as those future amounts are to be treated as compounded in accordance with paragraph (4). (1B) For the purposes of paragraph (1)(b), E’s post-implementation support scheme amount is the sum of all support scheme payments made in relation to any period after 31st March 2025 to E, or to a person on behalf of E, by virtue of, where E was immediately before they died— (a) an infected SSP recipient, an infection of E; (b) an affected SSP recipient, E being a bereaved partner of a person infected with HIV or Hepatitis C (or both). (2) The awards referred to in paragraph (1A)(a) are— (a) the basic financial loss award, (b) the additional financial loss (core) award, (c) the care (core) award, (d) where an offer to make an infected supplemental payment has been accepted— (i) any care (severe health condition) award, (ii) any financial loss (severe health condition) award, and (iii) any financial loss (PAYE earnings) award, (e) where an offer to make a further infected core payment has been accepted— (i) any additional financial loss (further core) award, and (ii) any care (further core) award, and (f) where an offer to make a further infected supplemental payment has been accepted— (i) any care (further severe health condition) award, (ii) any financial loss (further severe health condition) award, and (iii) any further loss (further reduced earnings) award. (2A) The future amounts referred to in paragraph (1A)(b) are a future amount (determined in accordance with paragraph (2B)) for each year of the period which— (a) begins with 2025, and (b) ends with the year in which the person in respect of whom E is an affected SSP recipient attained, or was expected to attain, the age of their healthy life expectancy. (2B) The future amount for a year is— (a) for 2025, the difference between— (i) the final year amount that was determined in relation to E in accordance with regulation 54(5), and (ii) E’s non-support scheme annual amount for 2025; (b) for any later year, E’s non-support scheme annual amount for that year. (2C) In paragraph (2B), “E’s non-support scheme annual amount”, in relation to a year, means the amount that would have been determined in relation to E for that year in accordance with regulation 53 if E’s affected core payment had included an amount by way of an affected financial loss award under that regulation. (3) Where the amount described in paragraph (1)(a) is greater than the amount described in paragraph (1)(b), the IBCA must pay an amount equal to the difference between those amounts to E’s personal representatives as a lump sum. (4) Each future amount mentioned in paragraph (1A) is to be treated as if it had been, at the beginning of each April during the period— (a) beginning with— (i) where E is an infected SSP recipient, the month in which the IBCS payment which comprised the award became payable (but if the IBCS payment became payable in April, that April is to be disregarded); (ii) where E is an affected SSP recipient, the month in which E’s affected core payment became payable (but if the affected core payment became payable in April, that April is to be disregarded), and (b) ending with the date of E’s death, compounded by the consumer price index over the 12-month period ending with the September before that April.
79 Payment of future financial loss and care awards where an SSP recipient dies
(1) Where the IBCA is notified that an infected SSP recipient or an affected SSP recipient (“E”) has died, the IBCA must determine which is the greater of— (a) E’s future loss (see paragraph (1A)), or (b) E’s post-implementation support scheme amount (see paragraph (1B)). (1A) For the purposes of paragraph (1)(a), E’s future loss is, where E was immediately before they died— (a) an infected SSP recipient, the sum of the future amounts (see regulation 7(1A)(b) and (1B)(b)) of each award mentioned in paragraph (2) determined in relation to E; (b) an affected SSP recipient, the sum of the future amounts determined in accordance with paragraphs (2A) to (2C), as those future amounts are to be treated as compounded in accordance with paragraph (4). (1B) For the purposes of paragraph (1)(b), E’s post-implementation support scheme amount is the sum of all support scheme payments made in relation to any period after 31st March 2025 to E, or to a person on behalf of E, by virtue of, where E was immediately before they died— (a) an infected SSP recipient, an infection of E; (b) an affected SSP recipient, E being a bereaved partner of a person infected with HIV or Hepatitis C (or both). (2) The awards referred to in paragraph (1A)(a) are— (a) the basic financial loss award, (b) the additional financial loss (core) award, (c) the care (core) award, (d) where an offer to make an infected supplemental payment has been accepted— (i) any care (severe health condition) award, (ii) any financial loss (severe health condition) award, and (iii) any financial loss (PAYE earnings) award, (e) where an offer to make a further infected core payment has been accepted— (i) any additional financial loss (further core) award, and (ii) any care (further core) award, and (f) where an offer to make a further infected supplemental payment has been accepted— (i) any care (further severe health condition) award, (ii) any financial loss (further severe health condition) award, and (iii) any further loss (further reduced earnings) award. (2A) The future amounts referred to in paragraph (1A)(b) are a future amount (determined in accordance with paragraph (2B)) for each year of the period which— (a) begins with 2025, and (b) ends with the year in which the person in respect of whom E is an affected SSP recipient attained, or was expected to attain, the age of their healthy life expectancy. (2B) The future amount for a year is— (a) for 2025, the difference between— (i) the final year amount that was determined in relation to E in accordance with regulation 54(5), and (ii) E’s non-support scheme annual amount for 2025; (b) for any later year, E’s non-support scheme annual amount for that year. (2C) In paragraph (2B), “E’s non-support scheme annual amount”, in relation to a year, means the amount that would have been determined in relation to E for that year in accordance with regulation 53 if E’s affected core payment had included an amount by way of an affected financial loss award under that regulation. (3) Where the amount described in paragraph (1)(a) is greater than the amount described in paragraph (1)(b), the IBCA must pay an amount equal to the difference between those amounts to E’s personal representatives as a lump sum. (4) Each future amount mentioned in paragraph (1A) is to be treated as if it had been, at the beginning of each April during the period— (a) beginning with— (i) where E is an infected SSP recipient, the month in which the IBCS payment which comprised the award became payable (but if the IBCS payment became payable in April, that April is to be disregarded); (ii) where E is an affected SSP recipient, the month in which E’s affected core payment became payable (but if the affected core payment became payable in April, that April is to be disregarded), and (b) ending with the date of E’s death, compounded by the consumer price index over the 12-month period ending with the September before that April.
One line that says what changes, such as "Halve the dog tax".
Who it helps, what it costs, what it fixes. It is what persuades people to support it.
How this law is officially changed
Solon does not know this law's official route yet. The proposal is recorded all the same, and the route appears here once its source is added.
A proposal here is not law. Support on Solon is evidence that people want the change; the official route says what it takes to make it law.
Sign in to file your proposal. What you have written stays on this page.
Sign in to file itThink it through
Ask what your change would do, who would gain and who would bear a cost, and where something like it is already law. The assistant reads your draft as it stands, cites the law and the studies it finds, and takes no side. What you file stays yours.